In order to increase the apoptotic rate of AML cell lines, we first combined our DHODH inhibitor with some selected chemotherapeutic agents that are classically used to treat AML, i.e., Ara-C, anthracyclines and decitabine. Here, DHODH is linked to acute myeloid leukemia.